ClinicalTrials.gg
Drug

Alpha-glycerophosphoric acid clinical trials

Its developmentBy Baxter Healthcare, step by step2 company-led studies, furthest phase 1: when each phase was reached, its deals, target and what is ahead.
studies test it
3
open now
0
in phase 3
0
first study started
2020

How each study uses alpha-glycerophosphoric acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
25 Aug 2014 · KABIVEN IN PLASTIC CONTAINER · NDA 200656 (FDA, Drugs@FDA; in a combination)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Sodium Glycerophosphate Injection
2

Studies by the year they started

3 studies that test it; most in 2025 (2)

Studies that test alpha-glycerophosphoric acid, by start year
YearStudies
20201
20252

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 2 · Other 1

Baxter Healthcare Corporation (2) · Ain Shams University (1)

Often tested with

Tested in the same studies.

Sodium phosphate (1)

Studies

Open first, then newest update. How each study uses alpha-glycerophosphoric acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

As the comparator · 1 — what is tested is compared with alpha-glycerophosphoric acid

Codes

What other systems call alpha-glycerophosphoric acid · ClinicalTrials.gg INT002897

  • MeSH (NLM) C029620alpha-glycerophosphoric acidConfirmed ClinicalTrials.gov, NLM

Also registered as sodium glycerophosphate (UNII RCS9EQ01V4 · RxNorm 1595589).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.